AG真人官方

On 21 Jul 2025, The GEO Group (GEO) filed a Form 4 for Executive Chairman & Director George C. Zoley covering transactions on 17 Jul 2025.

• Code F (tax withholding): 81,794 common shares were automatically surrendered at $25.22 to satisfy payroll taxes triggered by the vesting of restricted stock. This is not an open-market sale.
• Post-transaction ownership: Zoley still holds 4,132,853 common shares directly and 104,850 shares indirectly via family trusts, maintaining substantial economic exposure.
• Restricted stock update: Holdings now reflect 50,000 restricted shares and the vesting of 207,862 shares on the same date.

The filing is largely administrative and is unlikely to have a material effect on GEO鈥檚 share count or market sentiment.

Hims & Hers Health (HIMS) has filed a Form 144 disclosing CEO Andrew Dudum鈥檚 intention to sell up to 125,335 Class A shares (鈮� $6.21 million) through Fidelity Brokerage on or after 21 Jul 2025. The proposed block equals 0.06 % of the 215.5 million shares outstanding.

The notice also lists prior insider activity: entities tied to Dudum disposed of 鈮� 463,000 shares between 28 Apr and 16 Jul 2025, generating roughly $26.9 million in gross proceeds. Individual sales ranged from 2,792 to 128,127 shares.

No operational or financial metrics accompany the filing; Form 144 only signals planned insider sales. Although the volume is small relative to float, continued CEO selling can pressure sentiment. Investors may watch for additional filings, confirmation of a 10b5-1 plan, or further ownership changes.

Okta, Inc. (NYSE: OKTA) filed a Form 144 disclosing an intended sale of 12,000 common shares by insider Jonathan James Addison. The shares have an aggregate market value of approximately $1.10 million based on the price at the time of filing, and will be executed through Morgan Stanley Smith Barney LLC on or about 15 July 2025. The shares represent roughly 0.007 % of the 167.16 million shares outstanding, indicating a small, non-dilutive transaction.

The filing also reports that Addison, under a Rule 10b5-1 trading plan, sold 6,027 shares on 14 July 2025 for $554,523.18. The securities to be sold were acquired as restricted stock units (RSUs) on 15 Dec 2023. No details were provided about any material consideration other than the equity award itself.

Form 144s are advance notices and do not guarantee that the sale will occur, but they do signal insider intent. Given the modest size relative to Okta鈥檚 float and the existence of a pre-arranged 10b5-1 plan, the market impact is expected to be limited. Investors commonly monitor such filings for sentiment cues; however, the data here suggest an orderly diversification rather than a strategic shift.

Okta, Inc. (NYSE: OKTA) filed a Form 144 disclosing an intended sale of 12,000 common shares by insider Jonathan James Addison. The shares have an aggregate market value of approximately $1.10 million based on the price at the time of filing, and will be executed through Morgan Stanley Smith Barney LLC on or about 15 July 2025. The shares represent roughly 0.007 % of the 167.16 million shares outstanding, indicating a small, non-dilutive transaction.

The filing also reports that Addison, under a Rule 10b5-1 trading plan, sold 6,027 shares on 14 July 2025 for $554,523.18. The securities to be sold were acquired as restricted stock units (RSUs) on 15 Dec 2023. No details were provided about any material consideration other than the equity award itself.

Form 144s are advance notices and do not guarantee that the sale will occur, but they do signal insider intent. Given the modest size relative to Okta鈥檚 float and the existence of a pre-arranged 10b5-1 plan, the market impact is expected to be limited. Investors commonly monitor such filings for sentiment cues; however, the data here suggest an orderly diversification rather than a strategic shift.

Hims & Hers Health, Inc. (HIMS) 鈥� Form 144 filing

Insider Soleil Boughton has filed a Form 144 indicating an intent to sell 2,572 Class A shares through Fidelity Brokerage Services on or about 14 July 2025. The shares have an aggregate market value of $122,993.04 and account for roughly 0.001% of the company鈥檚 215.45 million shares outstanding, suggesting a limited impact on the public float.

The shares were acquired via restricted-stock vesting on 15 June 2025 and are being disposed of as compensation-related stock. The filer has also disclosed seven prior open-market sales in the past three months totaling 23,535 shares for ~$1.15 million in gross proceeds.

Because Form 144 is a notice of proposed sale, the transaction may or may not be executed, and it does not automatically imply negative operational information. Nonetheless, the continued pattern of insider selling can influence investor perception.

Concentrix Corporation (CNXC) 鈥� Form 144 key points

An affiliate of Concentrix has filed a Form 144 indicating an intent to sell up to 300,000 common shares. With 63,025,120 shares outstanding, the proposed sale represents roughly 0.48 % of the public float. The block is valued at $18.15 million (about $60.50 per share) and is slated to be executed through Goldman Sachs & Co. LLC on or around 8 July 2025 on the NASD market.

The seller acquired the shares on 25 September 2023 as consideration in a merger or acquisition, split into two lots of 150,000 shares. In addition, the filing discloses that the same parties have already disposed of 300,000 shares during the past three months through eleven separate trades, generating gross proceeds of approximately $16.63 million.

Form 144 notices signal the intention鈥攂ut not the obligation鈥攖o sell. Nevertheless, the disclosure can create near-term selling pressure and provides investors with visibility into insider disposition activity. The form contains no operating results, guidance, or other financial metrics.

Kura Sushi USA (NASDAQ: KRUS) filed its fiscal Q3 2025 Form 10-Q for the quarter ended 31 May 2025. The company now operates 76 restaurants, up from 63 a year ago, and plans to reach 79-81 units by fiscal year-end. Expansion, menu price increases and new store openings drove a 17.3 % year-over-year (YoY) sales increase to $74.0 million. Despite negative traffic, Q3 comparable restaurant sales fell only 2.1 % thanks to a 0.8-point price/mix benefit.

Profitability improved markedly. Q3 produced net income of $0.6 million (diluted EPS $0.05) versus a $0.6 million loss in the prior-year period. Restaurant-level operating profit reached $13.5 million (18.2 % margin), while corporate G&A leverage and lower litigation expense helped narrow the operating loss to $0.2 million. Nine-month results remain negative, however, with a $4.2 million net loss on $203.3 million of sales (+18.3 % YoY).

Cost dynamics:

• Food & beverage costs fell 90 bp YoY to 28.3 % of sales on pricing and supply-chain initiatives.
• Labor rose 50 bp to 33.1 % of sales as wage inflation outpaced price actions.
• Occupancy expense climbed to 7.5 % of sales, reflecting new unit leases.

Balance sheet strength. A November 2024 follow-on equity offering added $64.4 million net, boosting cash and marketable securities to $92.9 million (cash $47.1 m; ST investments $13.4 m; LT investments $32.5 m). The company has no debt and an undrawn $45 million revolver with parent Kura Japan. Total assets rose to $419.4 million, with lease liabilities of $166.0 million (current and long-term).

Cash flow & capex. Operating cash flow was $15.3 million YTD. Heavy new-unit build-out drove $84.2 million of investing outflows (capex $37 million; securities purchases $70 million). Net cash decreased $3.9 million, but liquidity remains ample.

Legal & risk items. The company incurred $5.1 million in wage-and-hour settlements and faces an unresolved California labor class action. Management believes additional losses are not yet estimable. New FASB disclosure standards (ASU 2023-07, 2023-09, 2024-03) will be adopted between fiscal 2025-2028.

Outlook. Management targets 15 total openings in fiscal 2025, implying two more restaurants in Q4. It expects continued revenue growth but also higher operating costs (labor, utilities, occupancy). No quantitative guidance was provided.